Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biohaven Ltd. Common Shares
(NY:
BHVN
)
15.63
+0.62 (+4.09%)
Streaming Delayed Price
Updated: 11:45 AM EDT, Oct 8, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biohaven Ltd. Common Shares
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO
July 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) Biohaven Pharmaceutical...
Via
Benzinga
Will This Biopharma Company Continue to Crush It?
July 17, 2021
Migraine sufferers certainly hope so.
Via
The Motley Fool
Analyst Ratings For Biohaven Pharma Hldgs
July 16, 2021
Analysts have provided the following ratings for Biohaven Pharma Hldgs (NYSE:
Via
Benzinga
Analyst Ratings For Biohaven Pharma Hldgs
July 12, 2021
Analysts have provided the following ratings for Biohaven Pharma Hldgs (NYSE:
Via
Benzinga
Analyst Ratings For Biohaven Pharma Hldgs
July 08, 2021
Within the last quarter, Biohaven Pharma Hldgs (NYSE:BHVN) ...
Via
Benzinga
The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay
July 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Alnylam Pharmaceuticals,...
Via
Benzinga
10 Biggest Price Target Changes For Monday
July 12, 2021
RBC Capital boosted Chipotle Mexican Grill, Inc. (NYSE:C...
Via
Benzinga
The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues
July 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Biohaven Pharmaceutical...
Via
Benzinga
Biohaven Rallies On Preliminary Nurtec Revenue Numbers: What Investors Need To Know
July 07, 2021
Biohaven Pharmaceutical Ltd. (NYSE:BHVN) released preliminar...
Via
Benzinga
The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO
July 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc...
Via
Benzinga
The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
July 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:...
Via
Benzinga
Topics
Product Recall
61 Biggest Movers From Yesterday
July 08, 2021
Gainers Newegg Commerce, Inc. (NASDAQ: NEGG) shares surged 148.4% to close at $67.57 on Wednesday after jumping around 42% on Tuesday. Mannatech, Incorporated (NASDAQ: MTEX)...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 07, 2021
Gainers Opiant Pharmaceuticals (NASDAQ:OPNT
Via
Benzinga
Here's Why Biohaven Pharmaceutical Is Soaring Today
July 07, 2021
Preliminary sales figures for the company's new migraine drug were much better than expected.
Via
The Motley Fool
Jim Cramer Says People Need To Know About Biohaven
July 07, 2021
Biohaven Pharmaceutical Holding Co Ltd (NYSE:BHVN) announced...
Via
Benzinga
Biohaven Stock Hits Record High As Migraine Drug Trounces Quarterly Forecasts
July 07, 2021
Biohaven crushed Wall Street's expectations for second-quarter sales of migraine drug Nurtec on Tuesday, leading BHVN stock to pop.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 07, 2021
Gainers Dare Bioscience (NASDAQ:DARE) shares increased by 51.97% to $2.31 during Wednesday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
Biohaven Pharmaceutical: Return On Capital Employed Insights
June 23, 2021
During Q1, Biohaven Pharmaceutical's (NYSE:BHVN) reported sales totaled $43.82 million. Despite a 28.93% in earnings, the company posted a loss of $235.88 million. In Q4, Biohaven...
Via
Benzinga
The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend
July 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 6) Ambrx Biopharma Inc. (NYSE:...
Via
Benzinga
Eli Lilly To Test Injectable Migraine Med Against Biohaven's Oral Nurtec In Head-To-Head Study
June 15, 2021
Eli Lilly And Co (NYSE: LLY) will conduct a head-to-head study comparing once-monthly injectable Emgality (galcanezumab-gnlm) with Biohaven Pharmaceutical...
Via
Benzinga
Biotechs Ready To Roar
June 13, 2021
The biggest event last week was the FDA decision to approve Biogen's drug aducanumab, a treatment for Alzheimer's disease. The decision will reverberate across the industry and the healthcare sector...
Via
Talk Markets
Biotech Movers During ASCO Week
June 12, 2021
The biotech sector performed well in a good ASCO week. And many biotech stocks were movers this week as a bullish sentiment took hold sparked by the Biogen Aduhelm approval.
Via
Talk Markets
The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts
June 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,...
Via
Benzinga
Photo of Biohaven Pharmaceuticals Ringing the Opening Bell Available on Business Wire's Website and the Associated Press Photo Network
June 08, 2021
From
Biohaven Pharmaceuticals
Via
Business Wire
Biohaven Pharmaceutical Insights: Return On Capital Employed
June 07, 2021
In Q1, Biohaven Pharmaceutical (NYSE:BHVN) posted sales of $43.82 million. Earnings were up 28.93%, but Biohaven Pharmaceutical still reported an overall loss of $235.88 million....
Via
Benzinga
Analyst Ratings for Biohaven Pharma Hldgs
June 01, 2021
Analysts have provided the following ratings for Biohaven Pharma Hldgs (NYSE:BHVN) within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 2...
Via
Benzinga
The Daily Biotech Pulse: Biohaven, Bristol-Myers Squibb Snag FDA Approvals, Iterum UTI Drug Review On Track, Centessa Pharmaceuticals Debuts On Nasdaq
May 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 27) BioCryst Pharmaceuticals,...
Via
Benzinga
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
May 31, 2021
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...
Via
Benzinga
Biohaven's Nurtec Wins FDA Approval As First Med to Prevent and Treat Migraine Attacks
May 28, 2021
The FDA has approved Biohaven Pharmaceutical Holding Co Ltd’s (NYSE: BHVN) dissolvable, Nurtec ODT (rimegepant), for preventive treatment in people who...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
May 27, 2021
Gainers Cellect Biotechnology (NASDAQ:APOP
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.